Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787007 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers
A Phase 1 study, sponsored by Ausio Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00787007: Completed Phase 1 study, sponsored by Ausio Pharmaceuticals.
NCT00787007 is a Phase 1 study that has completed, run by Ausio Pharmaceuticals. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00787007, a Phase 1 study, has completed, sponsored by Ausio Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is 1) to test the safety of S-equol in healthy volunteers and 2) to see how quickly S-equol enters the bloodstream, is distributed in the body, and broken down and removed, when taken with food or without food.
Interventions
- DRUG Placebo
- DRUG S-equol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00787007
The ClinicalTrials.gov registry entry for NCT00787007 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ausio Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00787007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00787007 about?
NCT00787007 is a clinical study titled "Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers". The purpose of this study is 1) to test the safety of S-equol in healthy volunteers and 2) to see how quickly S-equol enters the bloodstream, is distributed in the body, and broken down and removed, when taken with food or without food.
What is the current status of trial NCT00787007?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00787007?
The interventions under investigation include: Placebo (DRUG), S-equol (DRUG).
Who is sponsoring clinical trial NCT00787007?
This trial is sponsored by Ausio Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.